2023 | Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion-positive non-small cell lung cancer | CHIH-HSIN YANG ; Zhou, Caicun; Jänne, Pasi A; Ramalingam, Suresh S; Kim, Tae Min; Riely, Gregory J; Spira, Alexander I; Piotrowska, Zofia; Mekhail, Tarek; Garcia Campelo, Maria Rosario; Felip, Enriqueta; Bazhenova, Lyudmila; Jin, Shu; Kaur, Manmit; Diderichsen, Paul M; Gupta, Neeraj; Bunn, Veronica; Lin, Jianchang; N Churchill, Eric; Mehta, Minal; Nguyen, Danny | Expert review of anticancer therapy | 2 | 1 | |